Propranolol for familial cerebral cavernous malformation (Treat_CCM): study protocol for a randomized controlled pilot trial

BACKGROUND: Cerebral cavernous malformations (CCMs) are vascular malformations characterized by clusters of enlarged leaky capillaries in the central nervous system. They may result in intracranial haemorrhage, epileptic seizure(s), or focal neurological deficits, and potentially lead to severe disa...

Descripción completa

Detalles Bibliográficos
Autores principales: Lanfranconi, Silvia, Scola, Elisa, Bertani, Giulio Andrea, Zarino, Barbara, Pallini, Roberto, d’Alessandris, Giorgio, Mazzon, Emanuela, Marino, Silvia, Carriero, Maria Rita, Scelzo, Emma, Faragò, Giuseppe, Castori, Marco, Fusco, Carmela, Petracca, Antonio, d’Agruma, Leonardo, Tassi, Laura, d’Orio, Piergiorgio, Lampugnani, Maria Grazia, Nicolis, Enrico Bjorn, Vasamì, Antonella, Novelli, Deborah, Torri, Valter, Meessen, Jennifer Marie Theresia Anna, Salman, Rustam Al-Shahi, Dejana, Elisabetta, Latini, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218540/
https://www.ncbi.nlm.nih.gov/pubmed/32398113
http://dx.doi.org/10.1186/s13063-020-4202-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218540/
https://www.ncbi.nlm.nih.gov/pubmed/32398113
http://dx.doi.org/10.1186/s13063-020-4202-x

Ejemplares similares